WHY IT MATTERS: Patients using cannabis to manage anxiety or depression should be aware that without proper medical guidance on strain selection, THC-to-CBD ratios, and dosing, cannabis may be worsening the very symptoms they are trying to treat. CLINICAL OVERVIEW: Research from Canada is highlighting a parallel rise in cannabis use alongside increasing rates of anxiety and depression, raising important questions about the direction of causality and the role cannabis may be playing in mental health outcomes. The relationship between cannabis and mood disorders is complex, as individuals may be turning to cannabis to self-manage psychological distress while the substance itself, particularly high-THC products, can worsen anxiety and depressive symptoms over time.
Marijuana Use & Dangers for Adolescents & Young Adults
WHY IT MATTERS: Parents, school counselors, and young people themselves should understand that regular cannabis use during adolescence is not a benign habit but a potential accelerant for mental health problems that may require professional intervention. CLINICAL OVERVIEW: Adolescents and young adults represent a particularly vulnerable population when it comes to cannabis use, largely because the brain continues developing well into the mid-twenties, making it highly susceptible to the neurological effects of THC during this window. When cannabis use disorder co-occurs with underlying mental health conditions such as anxiety, depression, or early psychotic spectrum disorders, the clinical picture becomes substantially more complex and harder to treat.
Screaming, vomiting, and daily weed: The rise of ‘scromiting’ among chronic cannabis users
WHY IT MATTERS: If you use cannabis daily and experience recurring episodes of severe vomiting that hot showers seem to relieve, you should discuss cannabinoid hyperemesis syndrome with your physician before your next emergency room visit. CLINICAL OVERVIEW: Cannabinoid hyperemesis syndrome is a paradoxical condition in which heavy, long-term cannabis use causes cyclical episodes of severe nausea, vomiting, and abdominal pain, often relieved temporarily by hot showers or baths. The syndrome is thought to involve dysregulation of cannabinoid receptors in the gut and hypothalamus, particularly with chronic high-potency THC exposure, though the precise mechanism remains under active investigation.
The Office Is Issuing A Recall On Multiple Adult-Use Cannabis Products Tested By Keystone …
WHY IT MATTERS: Patients and adult consumers purchasing cannabis from licensed New York dispensaries should check current recall lists and verify with their dispensary that any products they have recently purchased or plan to purchase have not been flagged for removal. CLINICAL OVERVIEW: Product recalls in regulated cannabis markets typically arise when testing laboratories identify contaminants such as pesticides, heavy metals, microbial agents, or inaccurate potency labeling that fall outside state-mandated safety thresholds. When a testing facility’s results are called into question or when products are found to be non-compliant, state regulators are obligated to pull those items from dispensary shelves to protect consumers.
OCM issues precautionary recall for select cannabis products tested by Keystone Lab – CBS 6 Albany
WHY IT MATTERS: Patients relying on tested and labeled cannabis products from New York dispensaries should check the OCM recall list to confirm their specific products are safe to use and return any flagged items to their point of purchase. CLINICAL OVERVIEW: Regulatory bodies like the New York State Office of Cannabis Management have the authority to issue precautionary recalls when questions arise about the accuracy or integrity of third-party laboratory testing, which serves as the primary safety checkpoint between cultivators and consumers. Cannabis testing laboratories are responsible for verifying potency, pesticide levels, heavy metals, residual solvents, and microbial contamination, and any uncertainty in those results can expose patients and consumers to unquantified risks.
Does Weed Make You Harder or Easier to Manipulate? – Herb
WHY IT MATTERS: Patients who use cannabis recreationally or medicinally should understand that high-dose THC can temporarily impair judgment and increase vulnerability to social influence, particularly in unfamiliar settings or with strangers. CLINICAL OVERVIEW: Cannabis influences judgment and decision-making through its effects on the prefrontal cortex, where THC disrupts the normal signaling of the endocannabinoid system and impairs executive function, working memory, and risk assessment. These cognitive effects are dose-dependent and highly variable based on individual tolerance, cannabinoid ratios, and consumption patterns, meaning that susceptibility to poor judgment or social manipulation is not uniform across all users.
Rare Cannabinoid Company Expands Mood Collection with New THC-Free CBC Gummies …
WHY IT MATTERS: Patients exploring THC-free options for mood support should know that CBC products are now commercially available, but the clinical evidence base is still largely preclinical and has not yet established clear dosing guidelines or confirmed efficacy in human trials. CLINICAL OVERVIEW: Cannabichromene (CBC) is a non-intoxicating phytocannabinoid that interacts with the endocannabinoid system through mechanisms distinct from CBD and THC, including potential influence on anandamide availability rather than direct binding at CB1 or CB2 receptors. Early preclinical research points toward possible mood-related and anti-inflammatory effects, though human clinical trial data remains limited.
Modulating the endocannabinoid system in alcohol use disorder: A translational systematic …
WHY IT MATTERS: For patients struggling with alcohol use disorder who have not responded well to existing medications like naltrexone or acamprosate, ECS-targeted therapies in development could eventually offer a new pharmacological option that addresses the underlying neurobiology of craving and relapse. CLINICAL OVERVIEW: The endocannabinoid system plays a central role in regulating reward circuitry, stress response, and impulse control, all of which are disrupted in alcohol use disorder. Cannabinoid receptors, particularly CB1 and CB2, along with endogenous ligands like anandamide and 2-AG, modulate dopaminergic and GABAergic pathways that drive craving, withdrawal, and relapse behavior.
Study uncovers another reason not to skimp on sleep – ASU News
WHY IT MATTERS: Patients using cannabis to manage sleep should understand that poor sleep and impulsive substance use can reinforce each other in a cycle that is harder to break than either problem alone. CLINICAL OVERVIEW: Sleep deprivation does not simply make people tired; it measurably shifts decision-making toward impulsivity, which has direct consequences for substance use behaviors including cannabis and alcohol. When the brain is under-rested, the prefrontal cortex loses some of its regulatory grip over reward-seeking circuits, lowering the threshold for risky choices.
Many NC candidates support medical marijuana legalization | Raleigh News & Observer
WHY IT MATTERS: If North Carolina passes medical marijuana legislation, patients with chronic pain, cancer, epilepsy, and other qualifying conditions could gain legal access to regulated cannabis therapies that they currently must forgo or obtain through unregulated channels. CLINICAL OVERVIEW: North Carolina has seen repeated bipartisan legislative efforts to establish a medical cannabis program, yet the state remains one of a shrinking number without legal patient access. Candidates across party lines are increasingly voicing support for medical marijuana legalization, reflecting a shift in political calculus as public opinion has moved substantially in favor of patient access.